Agilent Technologies, Inc. $A Holdings Raised by Wellington Management Group LLP

Wellington Management Group LLP increased its position in Agilent Technologies, Inc. (NYSE:A) by 2.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 7,454,686 shares of the medical research company’s stock after purchasing an additional 198,253 shares during the period. Wellington Management Group LLP owned about 2.64% of Agilent Technologies worth $990,206,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the 4th quarter worth $26,000. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $26,000. Navalign LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. MV Capital Management Inc. bought a new stake in Agilent Technologies in the 4th quarter valued at $28,000. Finally, Entrust Financial LLC bought a new stake in shares of Agilent Technologies in the fourth quarter valued at about $31,000.

Analysts Set New Price Targets

Several analysts have recently weighed in on A shares. HSBC decreased their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Morgan Stanley lifted their target price on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Piper Sandler started coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Jefferies Financial Group started coverage on Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price on the stock. Finally, Barclays increased their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Trading Down 2.0%

A stock opened at $154.47 on Friday. The stock has a market cap of $43.63 billion, a price-to-earnings ratio of 30.41, a price-to-earnings-growth ratio of 2.72 and a beta of 1.25. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.62. The company has a fifty day moving average price of $140.30 and a two-hundred day moving average price of $127.04. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $163.75.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the firm posted $1.37 EPS. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.